Cart
sales@molnova.com
Methyl 2,5-dihydroxycinnamate
CAS No. 63177-57-1
Methyl 2,5-dihydroxycinnamate( —— )
Catalog No. M27654 CAS No. 63177-57-1
Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 177 | Get Quote |
|
| 50MG | 335 | Get Quote |
|
| 100MG | 500 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMethyl 2,5-dihydroxycinnamate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
-
DescriptionMethyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorApoptosis|BiP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number63177-57-1
-
Formula Weight194.186
-
Molecular FormulaC10H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (643.73 mM)
-
SMILESCOC(=O)\C=C\c1cc(O)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Oida Y, et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res. 2008 May 7;1208:217-24.
molnova catalog
related products
-
EGFR-IN-8
EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC. EGFR-IN-8 is a dual EGFR and c-Met inhibitor.
-
Lidocaine Hydrochlor...
Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.
-
Varlitinib
Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
